In a recent interview, OptimizeRx Chief Commercial Officer Theresa Greco discussed the company’s evolving strategy in the dynamic digital health space. She highlighted the firm’s focus on expanding its real-world evidence capabilities and using artificial intelligence to better support pharmaceutical clients and healthcare providers. Greco pointed to a strong pipeline, increased customer engagement and innovative partnerships as indicators of sustained momentum and long-term growth.
Greco also addressed the broader landscape of healthcare communication, emphasizing OptimizeRx’s role in delivering personalized, data-driven messaging to improve patient outcomes. She teased upcoming developments and expressed confidence in the company’s positioning for 2025 and beyond. Watch the full interview to hear more about OptimizeRx’s technology investments and market vision.